Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
2.
Ophthalmologe ; 117(3): 215-217, 2020 Mar.
Article in German | MEDLINE | ID: mdl-31713069

ABSTRACT

Penetrating keratoplasty in children is associated with very specific difficulties for the surgeon as well as for the patient and the parents. Special features are specific pediatric indications, which do not occur in adults, a more difficult examination and treatment adherence depending on the parents. Diseases with a favorable prognosis include keratoconus and herpetic keratitis. Especially sclerocornea and the Peters' anomaly often have a limited prognosis regarding vision and graft survival due to secondary malformations of the eye. In addition, younger age represents a risk factor. This is most likely due to the impaired examination during follow-up and reduced compliance. For successful penetrating keratoplasty in children the timing for the operation, in which the risk for the graft is weighed up against the risk for amblyopia, is crucial.


Subject(s)
Corneal Opacity , Corneal Transplantation , Child , Follow-Up Studies , Humans , Keratoplasty, Penetrating , Postoperative Complications , Retrospective Studies
3.
Klin Monbl Augenheilkd ; 235(3): 319-323, 2018 Mar.
Article in German | MEDLINE | ID: mdl-28192842

ABSTRACT

BACKGROUND: The conditions for long-term graft survival in infants and children are unfavorable, due to the different immunological features, the impaired clinical examination and the reduced compliance and treatment adherence. However, penetrating keratoplasty is often the only option to prevent amblyopia and there may be no alternative. We examined the different indications, graft survival and complications in two specialised centres. MATERIAL AND METHODS: We identified all patients who were under the age of 18 years at the time of their penetrating keratoplasty. We then assessed the electronic file on indications, graft failure, visual acuity, enucleation and further complications. RESULTS: A total of 104 eyes of 95 patients (54 % female) were identified. Median age at the time of surgery was 14 years (quartiles 8 and 16 years). Median follow-up was 2.7 years. The following indications were identified: keratoconus (39 %), penetrating injury (18 %), non-herpetic corneal scars (12 %), herpetic corneal scars (6 %), sclerocornea (3 %), chemical burn (3 %) and miscellaneous indications (19 %). Clear graft survival according to the Kaplan-Meier method ranged from 100 % (keratoconus) to 35 % (sclerocornea). Enucleation was only necessary in patients with penetrating injuries (n = 2). Kaplan-Meier analysis estimated the failure of all grafts after one year in infants. In older patients, 90 % of grafts were still clear at that time. CONCLUSION: Prognosis of penetrating keratoplasty in children is related to the indication, and therefore the underlying disease, as well as the patients' age. In particular, infants exhibited poor prognosis, with only a very short period of clear graft survival. In indications, keratoconus showed the best prognosis, whereas sclerocornea and penetrating injuries had the worst prognosis.


Subject(s)
Keratoplasty, Penetrating/methods , Postoperative Complications/diagnosis , Adolescent , Child , Child, Preschool , Eye Enucleation , Female , Follow-Up Studies , Graft Rejection/diagnosis , Graft Rejection/physiopathology , Graft Rejection/therapy , Graft Survival/physiology , Humans , Infant , Kaplan-Meier Estimate , Male , Patient Compliance , Postoperative Complications/physiopathology , Postoperative Complications/therapy , Primary Graft Dysfunction/diagnosis , Primary Graft Dysfunction/physiopathology , Primary Graft Dysfunction/therapy , Visual Acuity/physiology
5.
Klin Monbl Augenheilkd ; 234(9): 1161-1168, 2017 Sep.
Article in German | MEDLINE | ID: mdl-28514814

ABSTRACT

Purpose Central serous chorioretinopathy (CSC) is a commonly acquired maculopathy characterized by the accumulation of subretinal fluid at the posterior pole. This study aims to analyze optical coherence tomography angiography (OCTA) findings in patients with acute and chronic CSC and to compare them to conventional imaging methods. Methods A series of 43 consecutive eyes of 29 patients diagnosed with CSC and 18 eyes of 9 healthy control subjects were included in this retrospective study. The OCTA images were assessed and compared to conventional fluorescence (FAG) and indocyanine green angiography (ICG). Results All CSC patients demonstrated abnormal areas of focal hypo- and hyperperfusion in the choriocapillaris. These were particularly evident in patients with chronic atrophic CSC. FAG and ICG imaging revealed leakage points in 10 of 43 eyes and choroidal neovascularization (CNV) in 3 of 43 eyes. OCTA imaging confirmed leakage points in 4 out of 10 cases and choroidal neovascularization in 2 out of 3 cases. In one case, OCTA demonstrated a CNV which was not detectable by FAG/ICG. Conclusion OCTA reveals areas of focal hypo- and hyperperfusion in the choriocapillaris in patients with CSC. Due to the inability to detect plasma flow, OCTA is not suitable to detect leakage points in CSC with confidence. However, OCTA reliably detects CNV in CSC even in the absence of exudative activity and may, therefore, represent an important supplement in the diagnosis of CSC.


Subject(s)
Angiography/methods , Central Serous Chorioretinopathy/diagnostic imaging , Tomography, Optical Coherence/methods , Adult , Female , Fluorescein Angiography , Humans , Image Interpretation, Computer-Assisted/methods , Male , Middle Aged , Reference Values , Sensitivity and Specificity , Statistics as Topic , Subretinal Fluid/diagnostic imaging
6.
Klin Monbl Augenheilkd ; 234(9): 1146-1153, 2017 Sep.
Article in German | MEDLINE | ID: mdl-28380651

ABSTRACT

Background Optical coherence tomography angiography (OCTA) offers the possibility to visualize, non-invasively, blood vessels of the retina. In vascular tumors, especially hemangioblastomas in Hippel-Lindau disease, new information can be obtained with OCTA concerning structure of the tumor, tumor activity and treatment success. Patients Ten eyes of 10 patients with retinal hemangioblastoma in Hippel-Lindau disease were included. The age of the patients ranged from 19 years to 65 years (median 44 years). Results A total of 10 active and one inactive hemangioblastomas were examined with OCTA. In larger tumors, only the superficial blood flow could be visualized. Four hemangioblastomas were not treated due to their location near the optic nerve head. Six hemangioblastomas in the peripheral retina were treated with laser photocoagulation. In 4 eyes, a reduced blood flow could be shown directly after the treatment. The visualization of the perfusion was partially blocked after laser treatment. Conclusion OCTA enables innovative methods of pre- and postoperative assessment of retinal hemangioblastomas. It has the potential to give new information about the morphology, activity and effects of treatment. Prospective studies with longer follow-up are needed to evaluate the therapeutic relevance of this new imaging method.


Subject(s)
Angiography/methods , Hemangioblastoma/diagnostic imaging , Hemangioblastoma/surgery , Retinal Neoplasms/diagnostic imaging , Retinal Neoplasms/surgery , Tomography, Optical Coherence/methods , von Hippel-Lindau Disease/diagnostic imaging , von Hippel-Lindau Disease/surgery , Adult , Female , Follow-Up Studies , Humans , Laser Coagulation , Male , Middle Aged , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/surgery , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Reoperation , Young Adult
7.
Eye (Lond) ; 31(3): 372-378, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27768117

ABSTRACT

AimThe objective of the study was to evaluate the long-term results of allogenic penetrating limbo-keratoplasy. This method allows simultaneous transplantation of a corneal graft and limbal stem cells of the donor by means of eccentric trephination of the donor button.MethodThe data of 192 consecutive cases of allogenic penetrating limbo-keratoplasty from 1995 to 2015 were reviewed. These had been performed exclusively in eyes with complete failure of the limbal stem cells, in combination with deep corneal scarring. Indications were predominantly eye burns, inflammatory conditions, and congenital aniridia. Graft survival and rejection rates were assessed using Kaplan-Meier analysis.ResultsFollow-up averaged 2.1±2.2 years. Median graft survival was 3.4 years in eye burns, 3.9 years in inflammatory disease, and 3.2 years in congenital aniridia. Median survival was 3.9 years in the heterogenous group of other indications.ConclusionAllogenic limbo-keratoplasty is a suitable option used to treat patients with bilateral complete failure of the limbal stem cells and deep opacification of the central cornea. The main reasons for graft failure are the loss of graft-limbal stem cell functioning and endothelial graft rejection.


Subject(s)
Corneal Diseases/surgery , Keratoplasty, Penetrating/methods , Limbus Corneae/surgery , Stem Cell Transplantation/methods , Adult , Eye Burns/surgery , Female , Follow-Up Studies , Graft Survival/physiology , Humans , Immunosuppressive Agents/therapeutic use , Kaplan-Meier Estimate , Limbus Corneae/cytology , Male , Middle Aged , Steroids/therapeutic use , Visual Acuity/physiology
8.
Klin Monbl Augenheilkd ; 233(6): 713-6, 2016 Jun.
Article in German | MEDLINE | ID: mdl-27315291

ABSTRACT

Keratoconus leads to progressive thinning and protrusion of the cornea. Young patients exhibit the highest risk for progression. Corneal crosslinking was introduced in 1998 and is intended to prevent progression of keratoconus. Only a few prospective controlled trials have been published. Six randomised controlled trials have been published. All these trials confirmed the efficacy of crosslinking through keratometric data. In two trials, progression was reported in some patients of the treatment group. This indicates that not all patients benefit from corneal crosslinking. The risks of the procedure include corneal scarring, haze, endothelial cell damage and infections of the cornea. In order to avoid these risks, patients without progression should not be treated with crosslinking.


Subject(s)
Keratoconus/diagnostic imaging , Keratoconus/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Riboflavin/administration & dosage , Ultraviolet Therapy/methods , Cross-Linking Reagents/therapeutic use , Evidence-Based Medicine , Humans , Treatment Outcome
9.
Ophthalmologe ; 113(6): 457-62, 2016 Jun.
Article in German | MEDLINE | ID: mdl-27251331

ABSTRACT

BACKGROUND: Keratoconus is a progressive corneal disease with thinning and scarring of the cornea. Diagnostic and treatment options are usually evaluated in large prospective or retrospective trials. Big data and smart data provide the possibility to analyze routine data for clinical research. In this article we report the generation of a monocentric keratoconus registry by means of computerized data analysis of routine data. This demonstrates the potential of clinical research by means of routine data. METHODS: A "clinical data warehouse" was created from all available routine electronic data. At the time of first presentation, each eye was classified into one out of four categories: suspected, early disease, late disease and status postkeratoplasty. Through integration of multiple data sources the clinical course for each patient was documented in the registry. RESULTS: A total of 3681 eyes from 1841 patients were included. The median follow-up time was 0.54 years. Patient age was higher in the groups with more severe stages of keratoconus, the proportion of female patients was higher in the group of suspected keratoconus and patient age and male to female ratios showed statistically significant differences between the groups (p < 0.001). CONCLUSION: We were able to create a "clinical data warehouse" by linking multiple data sources and normalizing the data. With this tool we established a novel, monocentric keratoconus registry. Only the grading of disease severity and the exclusion of false positive results were carried out manually. In our opinion establishing a structured clinical data warehouse has a huge potential for clinical and retrospective studies and proves the value of the Smart Data concept.


Subject(s)
Data Mining/methods , Datasets as Topic/statistics & numerical data , Electronic Health Records/statistics & numerical data , Keratoconus/diagnosis , Keratoconus/epidemiology , Registries/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Female , Germany/epidemiology , Humans , Male , Middle Aged , Prevalence , Risk Factors , Young Adult
10.
Klin Monbl Augenheilkd ; 231(11): 1115-9, 2014 Nov.
Article in German | MEDLINE | ID: mdl-25340376

ABSTRACT

BACKGROUND: Cataract is one of the most common diseases in ophthalmology. Up to now the only way to estimate the total number of carried out surgeries in Germany were the surveys done by DOG, BVA, DGII and BDOC or reports of the federal statistical office. OBJECTIVES: Objective of this paper is to evaluate the annual quality reports of the Federal Joint Committee with a view to how the hospitals are participating in the nationwide comprehensive coverage concerning cataract surgery and if there is a continuing trend to more outpatient cataract surgeries in German eye hospitals. MATERIAL AND METHODS: The number of outpatient and inpatient cataract surgeries included in the annual quality reports of 2006, 2008 and 2010 were put into relation with population density for every provincial state. RESULTS: In 2006, 2008 and 2010 a total of 765,179 cataract surgeries were recorded. Median number of cataract surgeries per 1000 inhabitants showed an only slight increase (2006: 2.8; 2008 and 2010: 3.0; p = 0.82). The ratio of outpatient to inpatient surgeries showed only a slight increase from 0.84 (2006) to 0.86 (2010). CONCLUSIONS: Lack of spatial and temporal variations imply that hospitals take a part in supplying the population with cataract surgery. There is no trend to more outpatient cataract surgeries at the moment. This implies that there might be a stable patient population that is not suitable for outpatient care.


Subject(s)
Ambulatory Care/statistics & numerical data , Cataract Extraction/statistics & numerical data , Cataract/epidemiology , Cataract/therapy , Health Care Surveys , Practice Patterns, Physicians'/statistics & numerical data , Quality Assurance, Health Care/statistics & numerical data , Ambulatory Care/trends , Cataract Extraction/trends , Germany/epidemiology , Humans , Practice Patterns, Physicians'/trends , Prevalence
13.
Eye (Lond) ; 28(7): 857-62, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24858530

ABSTRACT

PURPOSE: We retrospectively studied the efficacy and safety of different surgical approaches to treating pediatric limbal dermoids with regard to intra and postoperative complications. METHODS: The data of 12 consecutive patients (14 eyes), who underwent monocentric surgery of a limbal demoid in the past 9 years, were retrospectively analyzed for intra and postoperative complications. Group one consists of eleven eyes: seven eyes with a bare-sclera deep lamellar excision of the dermoid and four eyes with an additional amniotic membrane transplantation subsequent to excision. Group two consists of three eyes: two eyes treated with Mitomycin C 0.02% over 2 min following the excision, and one eye treated with Mitomycin C and amniotic membrane transplantation after removal of the dermoid. Follow-up ranged from 2 to 53 months (median 17 months). RESULTS: Intraoperative complications did not occur in any of the patients. Postoperatively, all patients showed corneal reepithelialization within a week. Limbal stem cell deficiency with a pseudopterygium developed in four eyes, one treated with bare-sclera excision and the others with amniotic membrane transplantation. One pseudopterygium had to be removed surgically because of visual acuity deterioration. Not a single eye treated with Mitomycin C developed a pseudopterygium. CONCLUSIONS: The transplantation of amniotic membrane following removal of a limbal dermoid cannot prevent the occurrence of a pseudopterygium. However, the use of Mitomycin C seems to have a protective effect.


Subject(s)
Alkylating Agents/administration & dosage , Corneal Diseases/therapy , Dermoid Cyst/therapy , Eye Neoplasms/therapy , Limbus Corneae/pathology , Mitomycin/administration & dosage , Ophthalmologic Surgical Procedures , Amnion/transplantation , Child , Child, Preschool , Combined Modality Therapy , Corneal Diseases/drug therapy , Corneal Diseases/pathology , Corneal Diseases/surgery , Dermoid Cyst/drug therapy , Dermoid Cyst/pathology , Dermoid Cyst/surgery , Eye Neoplasms/drug therapy , Eye Neoplasms/pathology , Eye Neoplasms/surgery , Female , Humans , Intraoperative Complications , Male , Microscopy, Acoustic , Postoperative Complications , Retrospective Studies , Treatment Outcome , Visual Acuity/physiology
17.
Klin Monbl Augenheilkd ; 228(12): 1086-91, 2011 Dec.
Article in German | MEDLINE | ID: mdl-22167359

ABSTRACT

Optical coherence tomography provides high-resolution images of the anterior segment (AS-OCT). When used as a measuring tool, corneal thickness, anterior and posterior chamber depths, anterior chamber diameter and chamber angle configuration are defined reproducibly. In terms of an optical biopsy by cellular imaging, tissue infiltration, deformation and deposits can be analysed microstructurally. A comparison of pre- and post-operative, as well as long-term follow-up of pathological findings are possible. Examination with AS-OCT is a no-contact procedure, and is well tolerated by the patient. The following instruments were used: Visante-OCT and Cirrus HD-OCT (Carl Zeiss Meditec GmbH, Germany) and SS100 CASIA (Tomey Europe, Erlangen).


Subject(s)
Anterior Eye Segment/anatomy & histology , Ophthalmoscopes , Tomography, Optical Coherence/instrumentation , Equipment Design , Equipment Failure , Humans , Sensitivity and Specificity
18.
Ophthalmologe ; 108(10): 981-93; quiz 994, 2011 Oct.
Article in German | MEDLINE | ID: mdl-22037728

ABSTRACT

Hematological diseases can lead to ocular manifestations in up to 90% of patients and sometimes the ophthalmological findings are the presenting symptom of the disease. The ocular manifestation is often asymptomatic. The diagnosis can be difficult especially when the ocular manifestation represents the first symptoms. In most cases the conjunctiva and retina are involved and are particularly found in patients with anemia, leukemia, Hodgkin and non-Hodgkin lymphoma, myeloproliferative and myelodysplastic syndromes and coagulopathies. Even opportunistic infections in cases of hematological diseases can lead to ocular manifestations. For unexplained retinal alterations with hemorrhage and cotton-wool spots an underlying hematological disease should be excluded.


Subject(s)
Eye Diseases/diagnosis , Eye Diseases/therapy , Hematologic Diseases/diagnosis , Hematologic Diseases/therapy , Diagnosis, Differential , Eye Diseases/etiology , Hematologic Diseases/complications , Humans
SELECTION OF CITATIONS
SEARCH DETAIL